A new prostaglandin E1 analogue (TFC-612) prevents a decrease in motor nerve conduction velocity in streptozocin-diabetic rats
- 1 January 1988
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 150 (1) , 225-230
- https://doi.org/10.1016/0006-291x(88)90509-8
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Abnormalities of endoneurial microvessels and sural nerve pathology in diabetic neuropathyNeurology, 1987
- Fiber loss is primary and multifocal in sural nerves in diabetic polyneuropathyAnnals of Neurology, 1986
- Pathogenesis of diabetic neuropathyAnnals of Neurology, 1986
- The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemiaAnnals of Neurology, 1986
- ENDONEURIAL BLOOD FLOW AND OXYGEN TENSION IN THE SCIATIC NERVES OF RATS WITH EXPERIMENTAL DIABETIC NEUROPATHYBrain, 1984
- Effect of a new aldose reductase inhibitor, (E)-3-carboxymethyl-5-[(2E)-methyl-3-phenylpropenylidene]rhodanine (ONO-2235) on peripheral nerve disorders in streptozotocin-diabetic ratsDiabetologia, 1983
- Electron microscopical studies of vessels in diabetic peripheral neuropathy.Journal of Clinical Pathology, 1980
- Effects of insulin and dietary myoinositol on impaired peripheral motor nerve conduction velocity in acute streptozotocin diabetes.Journal of Clinical Investigation, 1975
- The Sorbitol Pathway and the Complications of DiabetesNew England Journal of Medicine, 1973
- OCULOMOTOR PALSY IN DIABETES MELLITUS: A CLINICO-PATHOLOGICAL STUDYBrain, 1970